Metabolomics

Dataset Information

0

1H HR-MAS NMR based metabolomics of cancer cells responding to two different doses of the diruthenium trithiolato complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1)


ABSTRACT: The trithiolato bridged diruthenium complex DiRu-1 [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ is highly cytotoxic against various cancer cell lines, but its exact mode of action remained unknown. The present 1H HR-MAS NMR based metabolomic study performed on the ovarian cancer cell lines A2780, its cisPt resistant variant A2780cisR and on the healthy cell line model HEK-293 treated with two doses of DiRu-1 was designed to reveal its mode of action. The resulting changes in the metabolic profile of the cell lines were studied using HR-MAS NMR of cell lysates and subsequent statistical analysis. We show that DiRu-1 in a 0.03 µM dose has significant impact on the levels of a number of metabolites, such as glutamine, glutamate, glutathione, cysteine, lipid, creatine, lactate, and acetate, especially pronounced in the A2780cisR cell line. Overall, the metabolic changes observed suggest that redox homeostasis, the Warburg effect and the lipid metabolism are affected by DiRu-1.

INSTRUMENT(S): Nuclear Magnetic Resonance (NMR)

PROVIDER: MTBLS1014 | MetaboLights | 2019-07-04

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
A_113.zip Other
A_113B.zip Other
A_114.zip Other
A_114B.zip Other
A_115.zip Other
Items per page:
1 - 5 of 354

Similar Datasets

2018-01-31 | MTBLS400 | MetaboLights
| PRJNA710968 | ENA
2010-12-08 | GSE25915 | GEO
2015-01-16 | MTBLS156 | MetaboLights
2018-02-06 | GSE110113 | GEO
| PRJNA432902 | ENA
| PRJNA711063 | ENA
2023-08-30 | GSE236602 | GEO
2025-05-19 | GSE294592 | GEO
| PRJNA986468 | ENA